Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells
🔦 buff.ly/wj2wwUX
@EmilianoCocco2 #NSCLC #RETfusion #FusionProtein
🔦 buff.ly/wj2wwUX
@EmilianoCocco2 #NSCLC #RETfusion #FusionProtein
November 26, 2025 at 9:01 AM
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells
🔦 buff.ly/wj2wwUX
@EmilianoCocco2 #NSCLC #RETfusion #FusionProtein
🔦 buff.ly/wj2wwUX
@EmilianoCocco2 #NSCLC #RETfusion #FusionProtein
Researchers @biomedizin.unibas.ch developed cartilage implants from nasal septum cells, and showed that allowing them to mature for two weeks improved outcomes. 🔬Congratulations to all contributors.
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
September 18, 2025 at 7:30 AM
Researchers @biomedizin.unibas.ch developed cartilage implants from nasal septum cells, and showed that allowing them to mature for two weeks improved outcomes. 🔬Congratulations to all contributors.
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
doi.org/10.1126/scit...
#Immunotherapy #CancerImmunology #FusionProtein #PD1IL2v #TCellTherapy
A CD38 "baitbody" to support safe blood products for multiple myeloma patients receiving Daratumumab and Isatuximab.
onlinelibrary.wiley.com/doi/full/10....
#baitbody, #daratumumab, #felzartamab, #isatuximab, #transfusionmedicine, #antibody, #fusionprotein, #bloodcompatability, #CD38, #MM
onlinelibrary.wiley.com/doi/full/10....
#baitbody, #daratumumab, #felzartamab, #isatuximab, #transfusionmedicine, #antibody, #fusionprotein, #bloodcompatability, #CD38, #MM
Resolving the Interference of Anti‐CD38 Antibodies on Blood Compatibility Assays Using CD38 “Baitbodies” Approach
Blood transfusion safety depends on swift blood compatibility testing. Alloantibodies recognizing these blood group antigens determine blood compatibility, and the transfusion of incompatible blood c...
onlinelibrary.wiley.com
January 5, 2026 at 10:33 AM
A CD38 "baitbody" to support safe blood products for multiple myeloma patients receiving Daratumumab and Isatuximab.
onlinelibrary.wiley.com/doi/full/10....
#baitbody, #daratumumab, #felzartamab, #isatuximab, #transfusionmedicine, #antibody, #fusionprotein, #bloodcompatability, #CD38, #MM
onlinelibrary.wiley.com/doi/full/10....
#baitbody, #daratumumab, #felzartamab, #isatuximab, #transfusionmedicine, #antibody, #fusionprotein, #bloodcompatability, #CD38, #MM
Antibody Therapeutics (IF=4.5, Oxford University Press) ⚡ Review Highlight -Challenges and solutions for the downstream purification of therapeutic proteins
academic.oup.com/abt/article/...
#biologics #proteinpurification #downstreamprocessdevelopment #fusionprotein
academic.oup.com/abt/article/...
#biologics #proteinpurification #downstreamprocessdevelopment #fusionprotein
Challenges and solutions for the downstream purification of therapeutic proteins
Statement of Significance: The diversity of protein structures has led to an increased complexity of product- and process-related impurities. The article s
academic.oup.com
May 31, 2026 at 8:37 PM
Antibody Therapeutics (IF=4.5, Oxford University Press) ⚡ Review Highlight -Challenges and solutions for the downstream purification of therapeutic proteins
academic.oup.com/abt/article/...
#biologics #proteinpurification #downstreamprocessdevelopment #fusionprotein
academic.oup.com/abt/article/...
#biologics #proteinpurification #downstreamprocessdevelopment #fusionprotein
Calcineurin-binding protein 1 (#CABIN1) directly binds to the #MEF2D #FusionProtein, thereby affecting cell survival and modulating the expression of core regulatory factors of BCP-ALL in the MEF2D::HNRNPUL1 cell lines.
#OpenAccess: doi.org/10.1038/s413...
#OpenAccess: doi.org/10.1038/s413...
December 29, 2025 at 12:30 PM
Calcineurin-binding protein 1 (#CABIN1) directly binds to the #MEF2D #FusionProtein, thereby affecting cell survival and modulating the expression of core regulatory factors of BCP-ALL in the MEF2D::HNRNPUL1 cell lines.
#OpenAccess: doi.org/10.1038/s413...
#OpenAccess: doi.org/10.1038/s413...
This review of purification strategy of therapeutic proteins received 23 citations already.
#Downstream #Purification #TherapeuticProtein #mAba #FusionProtein #VHH #scFv
@antibodytx.bsky.social
#Downstream #Purification #TherapeuticProtein #mAba #FusionProtein #VHH #scFv
@antibodytx.bsky.social
Challenges and solutions for the downstream purification of therapeutic proteins
Statement of Significance: The diversity of protein structures has led to an increased complexity of product- and process-related impurities. The article s
doi.org
July 22, 2025 at 4:54 AM
This review of purification strategy of therapeutic proteins received 23 citations already.
#Downstream #Purification #TherapeuticProtein #mAba #FusionProtein #VHH #scFv
@antibodytx.bsky.social
#Downstream #Purification #TherapeuticProtein #mAba #FusionProtein #VHH #scFv
@antibodytx.bsky.social
Fusion protein controls design of #photosynthesis platform - http://www.uni-mainz.de/presse/18298_ENG_HTML.php #fusionprotein #chloroplast http://t.co/1lLikSPZCl
December 12, 2024 at 8:27 PM
Fusion protein controls design of #photosynthesis platform - http://www.uni-mainz.de/presse/18298_ENG_HTML.php #fusionprotein #chloroplast http://t.co/1lLikSPZCl